key: cord-0919882-0s1a7u6k
authors: Luo, Jessica; Rosales, Megan; Wei, Guo; Stoddard, Gregory J; Kwok, Alvin C; Jeyapalina, Sujee; Agarwal, Jayant P
title: Hospitalization, Mechanical Ventilation, and Case-Fatality Outcomes in US Veterans with COVID-19 Disease between years 2020-2021
date: 2022-04-21
journal: Ann Epidemiol
DOI: 10.1016/j.annepidem.2022.04.003
sha: 4c783fbe3466519128a649fe289d107fd3b4d592
doc_id: 919882
cord_uid: 0s1a7u6k

PURPOSE: Although veterans represent a significant proportion (7%) of the USA population, the COVID-19 disease impact within this group has been underreported. To bridge this gap, this study was undertaken. METHOD: A total of 419,559 veterans, who tested positive for COVID-19 disease in the Veterans Affairs hospital system from March 1(st), 2020 to December 31(st), 2021 with 60-days follow-up, was included in this retrospective review. Primary outcome measures included age-adjusted incidences and relative incidences of COVID-19 hospitalization, mechanical ventilation, and case-fatality outcomes. RESULTS: Of this veteran cohort with COVID-19 disease, predominately 85.7% were male, 59.1% were White veterans, 27.5% were ages 50-64, and 40.5% were obese. Although Black veterans were at 31% higher relative risk (RR) for hospitalization incidences, they had a similar risk RR for in-hospital deaths compared to the referent. Asian, American Indian/Alaska Native races, advanced age ≥65, and the underweight were at high RR for mechanical ventilation use and in-hospital deaths compared to respective referent groups. Veterans who are ≥85 years old had a nearly five-fold higher incidence of death compared respective referent group. The monthly outcomes for hospitalization, ventilation, and case-fatality data showed decreasing trends with time. CONCLUSION: An increased incidence of death was associated with age ≥65 years and underweight veterans compared to the referent group. Age-adjusted data, however, did not show any increased incidence of death in Black veterans compared to White veterans. RATINGS OF THE QUALITY OF THE EVIDENCE: 3 (Case-control studies; retrospective cohort study)

Earlier coronavirus disease 2019 (COVID- 19) pandemic reports found the association of severe disease with advanced age, race, male sex, and preexisting comorbidities 1, 2 . The United States (US) veterans, with many of the aforementioned risk factors, are a vulnerable population and also susceptible to service-related physical, mental, and social issues that places them at a higher risk of experiencing poorer outcomes during this pandemic [3] [4] [5] [6] [7] . Today, only a few studies reported the veterans' COVID-19 symptom severity outcomes [8] [9] [10] [11] [12] .

The United States Department of Veterans Affairs (VA) patient population is unique, because they are eligible to receive healthcare services within the nationwide network of VA hospitals.

As such, the socioeconomic disparity that affects healthcare access within this cohort is somewhat uniform. Due to the unique VA system separate from the general public, veterans have been largely excluded from the national epidemiological COVID-19 studies. The limited earlier studies assessing COVID-19 impact on veterans were restricted to short periods and regional VA facilities [8] [9] [10] [11] [12] [13] [14] [15] . This study reports demographics and outcomes (hospitalization, mechanical ventilation (MV), and case-fatality) of COVID-19 infected veterans in VA facilities for the years 2020 and 2021. Furthermore, we assessed monthly hospitalization, mechanical ventilation, and case-fatality rates for each age group to understand whether any improvement in clinical care might have occurred during the onset of this pandemic.

Using local (VA) Institutional Review Board approval (#00133238), the VA COVID-19 Shared Data Resource was accessed for collecting patient data for this retrospective study. For this study, the VA COVID-19 Shared Data Resources were used, which is a part of VA Informatics and Computing Infrastructure (VINCI). This shared data resource domain specifically tracks all COVID-19 infected veteran patients within the national VA hospital system with veteran's COVID positivity data traced from the National Surveillance Tool that gathers data from publicly available databases to track COVID- 19 for hospitalization were calculated for the entire cohort. RRs for ventilation and case-fatality were calculated only for the hospitalized cohort. For each demographic, RR for each outcome compared to a referent group was presented with two-sided 95% confidence intervals (CI).

Line graphs were used to visualize the change in hospitalization, ventilation, and case-fatality rates over time by age. 60-day outcome rates for each index month were calculated as the number of veterans with an ID within that month who experienced the outcome within 60-days of their ID divided by the total number of veterans with an ID in that month. The p-values for linear trend over time for each demographic group were obtained by sub-setting the data by demographic group and performing modified Poisson regression with hospitalization, ventilation, or case-fatality as the outcome variable and month as a continuous predictor variable.

Two-sided significance for all tests was assessed at the p<0.05 level. All analyses were completed with R version 4.2.0. A detailed description of the analysis is given in the eMethods section. Interestingly, monthly hospitalization data trended down over the study period (-34%; Figure 1) with statistical significance (p<0.001) for all age groups. groups. The age-adjusted case-fatality rates were highest in NHPI (14.7%), AIAN (13.6%), and Asian (12.9%) veterans, ages >65 years, and the normal weight (17.7%) ( Table 1) .

The relative incidence of case-fatality was 25% higher in the AIAN race compared to White veterans (RR=1.25, 95%CI 1.02-1.53). Compared to the 50-64 age referent, the relative incidence of death in veterans <50 years old was significantly reduced, while those >64 years of age were significantly increased (p<0.001). Overall, >85 years old veterans showed a nearly five-fold higher incidence of death compared to the 50-64 referent age group. Compared to the normal weight referent, the morbidly obese veterans only exhibited a relative 14% increase in the incidence of case-fatality (RR=1.14, 95%CI 1.04-1.24) with a significant level (p=0.01). Also, underweight veterans had a relative 26% higher incidence of case-fatality (RR=1.26, 95%CI

1.15-1.37) ( Table 2) . Although monthly case-fatality rates for the age groups <40 remained constant, all other groups depicted exponentially decreasing trends, which appeared to plateau around July to August 2020.

This study describes the demographic and severity outcomes for 419,559 COVID-19 positive veterans treated within the VA hospital system between March 1 st , 2020, and December 31 st , 2021. Among all COVID-19 positive veterans, the hospitalization rate was 14.0%. Within the hospitalized cohort of 58,728 veterans, 11.5% were mechanically ventilated (MV), and 14.7% have succumbed to the disease. The MV data was comparable to national data, which showed 13.3% of the hospitalized placed on MV 17 . However, the case-fatality rate for hospitalized veterans (14.7%) was slightly higher than the national average of 11.5% 18 . This difference could be attributed to the makeup of the hospitalized veterans, which was a relatively older population than the national average.

During the onset of a pandemic, studies reported inequities in systemic health and socioeconomic factors that put racial and ethnic minority groups at increased risk of getting sicker and dying from COVID-19 [19] [20] [21] [22] [23] . Our findings showed higher hospitalization, but not death rates, in Black veterans and Hispanic/Latino than in White veterans. Some previous studies supported our findings [8] [9] [10] 19, 24 . High infection rates may be explained by the higher community spread of COVID-19 amongst these groups due to their living situations (densely populated communities, multigenerational homes, overrepresentation in jails/prisons/detention centers), work conditions (essential workers, lack of paid sick leave), health conditions (lack of health insurance, healthcare access or utilization, underlying comorbidities, limited health education, lower life expectancy), and transportation limitations (dependency on public transportation) 20,21,25-29 .

However, it appears that adequate in-hospital care and management of illness provided within the VA hospital system may have played a role in reducing the case-fatality incidence within Black veterans, Hispanic/Latino, Asian, and NHPI groups. However, the AIAN group showed a significantly increased (P>0.05) incidence of in-hospital death.

Although AIAN veterans only comprised 0.7% of those who tested positive and were hospitalized in our study, they have a relative 36% higher incidence of MV and a relative 25% higher incidence of death than White veterans, supporting the current national CDC data. 30, 31 Similarly, other studies reported, within the AIAN general population, the COVID-19 incidence (3.3x) 32 and mortality (1.8-2.2x) 26,33 rates were higher: especially in the younger population 26, 32, 34 . Interestingly, during the 2009 influenza A(H1A1), AIAN persons were reported to have suffered disproportional deaths when compared to White persons, 35, 36 indicating possible social, lifestyle, healthcare, and financial disparities. Along with the aforementioned social inequalities, the AIAN groups are additionally more likely to live in rural or small-town areas, lack plumbing, and running water, and lack the infrastructure to receive quicker medical care [25] [26] [27] [28] [29] 37 . Furthermore, compared to veterans of other races, AIAN veterans have higher unemployment rates, a geographical disadvantage in receiving VA healthcare services, comorbidities, and have more service-connected disabilities 38 . Regardless, it is important to acknowledge these disparities exist and identify those who are at risk early to prioritize resources and services and promote community awareness for limiting poor outcomes associated with this and any highly future infectious diseases. More importantly, there are still gaps that exist in public health data collection for the AIAN groups, 32 which could be overcome with a structured community awareness education in collaboration with respective tribal leaders.

It is now widely accepted that the risk of severe COVID-19 illness increases sharply with elevated BMI. However, the CDC data suggests a non-linear relationship between BMI and symptom severity 17 . Our age-adjusted data show that while underweight and morbidly obese veterans have increased incidences of hospitalization, overweight and obese veterans have lower incidences, supporting the CDC data (Table 2) . Perhaps, these differences may be related to the other confounding variables, such as comorbidities, not controlled in this study. Underweight veterans appeared to have a relative 42% higher incidence of hospitalization within our dataset and a relative 26% higher incidence of death than normal-weight referent. This finding was supported by an earlier veteran study 39 . In a New York study with similar findings, underweight patients had higher odds of death (OR=1.44, 95%CI 1.08-1.92), but not with MV (OR=0.85, 95%CI 0.57-1.27) 40 . The authors reasoned that the underweight groups might have deferred MV on the basis of goals of care discussion 40 . A Korean study also found higher mortality risks (crude hazard ratio=2.56) in the underweight cohort 41 . A US study across 800 hospitals of COVID-19 outcomes in 2020 found higher hospitalization but not ICU admission, MV, or death risks in the underweight cohort 17 . It is reported that COVID-19 causes inflammation leading to cachexia after an acute illness, and malnourished patients, especially those lacking in protein, have impaired immune response and limited reserve for fending off infection 42 . Regardless of the reasons, underweight patients did not appear to tolerate the COVID-19 infection well, and they need to be closely monitored.

Obesity is reported to be a risk factor for symptom severity with COVID-19 infections [43] [44] [45] [46] [47] [48] . Our finding supports these national data for MV. Our age-adjusted data for obese veterans showed a relatively 86% higher incidence of hospitalization and a relatively 14% (p<0.001) higher incidence amongst morbidly obese veterans. Consistent with previous studies, the incidence of MV increased with increasing BMI, with morbidly obese veterans having a two-fold increased incidence of MV than the referent group 17 . Importantly, morbidly obese patients had increased incidences of hospitalization (P=0.01), ventilator use (p<0.001), and hospital fatality (p=0.01). In summary, the risk of MV appeared to increase as BMI increases over 25kg/m 2 , which demonstrated an increase in disease severity with weight, with the morbidly obese experiencing the worst outcomes in terms of hospitalization, MV, and death. Contrary to published data, lower incidences were seen in case-fatality for overweight and obese veterans, potentially indicating the role and importance of healthcare access in limiting case-fatalities.

As expected, an increase in age increases the relative incidences of hospitalization, MV, and death. In our study, those who were >85 years old had over a five-fold increase in the incidence of death, which supported the national trend. The CDC has reported 8 out of 10 US COVID-19 deaths have been in adults ages >65 49 , which is lower than the reported death in veterans, where 86.5% of the cases were within this age group. These numbers could be related to the average age of the VA cohort. A United Kingdom study found those >75 years old had 13-times a mortality risk compared to those <65 years old, and those >75 years old without additional risk factors had four times the risk of mortality compared to those <65 years old 50 . Although advanced age was an independent risk factor for COVID-19 mortality 50 , the elderly are more likely to have underlying medical conditions, decreased immune functions, and live in nursing home communities where the virus can quickly spread. 51 Furthermore, they are more likely to present with atypical symptoms, such as falls, reduced mobility, generalized weakness, or delirium, that delay diagnosis and care 52 .

In our study, the relative incidence of MV decreased as age increased, >65 years old, but not for veterans who are >85 years. This may be attributed to advanced directives since the mortality of patients in their 80s or 90s placed on ventilators has been very high, even in the best of circumstances 53 . A US epidemiological study found 50% of those aged >85 who were ventilated died in the hospital 53 . Thus, they may not have received MV unless they were severely ill, which is reflected in the number of cases (n=192 [6.8%]).

Monthly rates of hospitalization (-34.1%; p<0.001), MV (-17.4%; p<0.001), and death (-14.1%; p<0.001) improved as 2021 progressed. At first, it would seem that MV and death were decreasing simply because hospitalization was decreasing, where hospitalization was more related to the severity of illness and spread of disease than to medical care. However, when looking at MV and death, the cohort being followed was only hospitalized patients, where the outcomes are affected by medical care rather than outside influences such as a downward trend in infections within the community. Perhaps during the initial months, the more susceptible veterans contracted and succumbed to the disease faster, but as the disease spread through the less susceptible population, the trends plateaued. Another possible explanation is the improved management of disease through a better understanding of COVID-19 by the providers and the later availability of treatment modalities at the VA hospital system's disposal. It is worth noting that MV rates spiked for the age groups 40-49 during May and 75-84 during June, which echoed the increased incidence of cases during that period 54 . Furthermore, the spike coincided with the availability of more ventilators as part of the VA's COVID-19 response plan. The central Veterans Hospital Administration provided more ventilators, medical equipment and supplies, pharmaceuticals, and acquisition and logistical support to the local VA hospital through VA National Acquisition Center 55 . Moreover, in a study assessing ICU capacity during 2020 in VA hospitals, the April and May months exceeded capacity and experienced strain in ICU care that resulted in a nearly two-fold increase in the relative incidence of mortality compared to low demand months 13 , supporting our overall data. Spikes were seen in the 18-29 group, but the changes over time were insignificant (p=0.49). This may be attributed to the overall small number (n=20 [0.3%]) of veterans ventilated in this age group. Also, there was an overall spike in hospitalization and MV use between April 2021 to June 2021, perhaps attributable to a more virulent delta variant.

There are several limitations to the study. This is a retrospective study that utilized data from the VA hospital system, which is not generalizable since veterans are relatively older than the general population. Hospitalization, MV, and death of veterans data were taken only from the hospitalized within the nationwide VA hospital system. Therefore, those treated outside the VA hospital system were excluded from this study. Finally, besides age, the risks were not adjusted for other confounding variables such as race, socioeconomic factors, comorbidities, and medications.

The variables associated with COVID-19 disease severity in veterans are race, advanced age, obesity for MV, and underweight and advanced age for in-hospital death. The overall management and outcomes for COVID-19 patients within the VA hospital system improved and 

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Jay Agarwal reports financial support was provided by Gilead Sciences Inc. Sujee Jeyapalina reports a relationship with Gilead Sciences Inc that includes: funding grants. Greg Stoddard reports a relationship with Gilead Sciences Inc that includes: funding grants. 

Risk factors for severe and critically ill COVID-19 patients: A review

Covid-19: risk factors for severe disease and death

Understanding the health of veterans who are homeless: A review of the literature

Prescription opioid misuse and its correlates among veterans and military in the United States: A systematic literature review

A scoping review of military veterans involved in the criminal justice system and their health and healthcare

Delays in Seeking Health Care: Comparison of Veterans and the General Population

US veterans and their unique issues: enhancing health care professional awareness

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10131 US Veterans With SARS-CoV-2 Infection

COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study

Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study

Risk for In-Hospital Complications Associated with COVID-19 and Influenza -Veterans Health Administration

Infection in Patients Treated at a Large Veterans Affairs Medical Center

Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic

Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System

Coronavirus disease 2019 in veterans receiving care at veterans health administration facilities

A modified poisson regression approach to prospective studies with binary data

Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death -United States

COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis

Hospitalization and Mortality among Black Patients and White Patients with Covid-19

The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities

Differential occupational risk for COVID-19 and other infection exposure according to race and ethnicity

Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City

COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities

Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals

American Indian and Alaska Native People: Social Vulnerability and COVID-19

COVID-19 Mortality Among American Indian and Alaska Native Persons -14 States

Outcomes of COVID-19: disparities in obesity and by ethnicity/race

Race/Ethnicity, Underlying Medical Conditions, Homelessness, and Hospitalization Status of Adult Patients with COVID-19 at an Urban Safety-Net Medical Center

Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income

COVID-19 Mortality Among American Indian and Alaska Native Persons -14 States

COVID-19 Incidence and Mortality Among American Indian/Alaska Native and White Persons -Montana

COVID-19 Among American Indian and Alaska Native Persons -23 States

Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study

SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years -United States

Deaths Related to 2009 Pandemic Influenza A (H1N1) Among American Indian/Alaska Natives-12 States

A case-control study of risk factors for death from 2009 pandemic influenza A(H1N1): is American Indian racial status an independent risk factor?

American Indian Reservations and COVID-19: Correlates of Early Infection Rates in the Pandemic

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 -COVID-NET, 14 States

Body mass index (BMI) and outcomes of SARS-CoV-2 among US veterans

BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID-19 in New York

Analysis of Mortality and Morbidity in COVID-19 Patients with Obesity Using Clinical Epidemiological Data from the Korean Center for Disease Control & Prevention

Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers

Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets

Renal denervation improves chronic intermittent hypoxia induced hypertension and cardiac fibrosis and balances gut microbiota

Obesity in patients with COVID-19: a systematic review and meta-analysis

Obesity aggravates COVID-19: An updated systematic review and meta-analysis

Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis

Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis

At greater risk of requiring hospitalization of dying if diagnosed with COVID-19 Web site

Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants

Obesity a risk factor for increased COVID19 prevalence, severity and lethality (Review)

Atypical presentation of COVID-19 in hospitalised older adults

The epidemiology of mechanical ventilation use in the United States

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy